BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16038330)

  • 1. [Non-alcoholic fatty liver--life of overindulgence with fatty liver].
    Füessl HS
    MMW Fortschr Med; 2005 Jun; 147(25):4-6, 8. PubMed ID: 16038330
    [No Abstract]   [Full Text] [Related]  

  • 2. Alcoholic and nonalcoholic forms of fatty liver disease.
    Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatty liver: frequent and not completely harmless].
    Lang C; Georgi A; Gubler C
    Praxis (Bern 1994); 2013 Sep; 102(18):1089-101. PubMed ID: 24005067
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
    Lee JY; Kim KM; Lee SG; Yu E; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Hepatol; 2007 Aug; 47(2):239-44. PubMed ID: 17400323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterogeneous steatosis. Echographic aspects].
    Scherrer A; Menu Y; Pariiente A; Laissy JP; Grenier P; Nahum H
    J Radiol; 1984 Jan; 65(1):25-9. PubMed ID: 6699799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease.
    Bayard M; Holt J; Boroughs E
    Am Fam Physician; 2006 Jun; 73(11):1961-8. PubMed ID: 16770927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Noninvasive diagnosis of fatty liver disease].
    Qu Y; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):155-7. PubMed ID: 20196962
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the clinical picture of fatty degeneration of the liver and fatty liver].
    Teichmann W; Lindemann A
    Z Gesamte Inn Med; 1967 Sep; 22(17):509-14. PubMed ID: 5591413
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of alcoholic and non-alcoholic fatty liver].
    Stremmel W; Blechacz B; Herrmann T; Rost D; Mueller S
    Internist (Berl); 2001 Dec; 42(12):1641-2, 1645-50. PubMed ID: 11793603
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatty liver--current look at the old disease.
    Mach T
    Med Sci Monit; 2000; 6(1):209-16. PubMed ID: 11208312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
    Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
    Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAFLD and cardiovascular risk: direct evidence for the tale of two ages.
    Lonardo A; Loria P
    Am J Gastroenterol; 2009 Jul; 104(7):1851-2. PubMed ID: 19574981
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on non-alcoholic fatty liver disease in children.
    Papandreou D; Rousso I; Mavromichalis I
    Clin Nutr; 2007 Aug; 26(4):409-15. PubMed ID: 17449148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver steatosis: recent advances.
    Thaler H
    Recenti Prog Med; 1990 Jun; 81(6):420-5. PubMed ID: 2251448
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-alcoholic steatohepatitis].
    Rakov AL; Gorbakov VV; Vecherinina OO
    Voen Med Zh; 2006 Jul; 327(7):33-9. PubMed ID: 16977879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.